Plasma free amino acid profiling as metabolomic diagnostic and prognostic biomarker in paediatric cancer patients: a follow-up study

被引：0

作者：

Anna Synakiewicz

Anna Stanislawska-Sachadyn

Malgorzata Sawicka-Zukowska

Grazyna Galezowska

Joanna Ratajczyk

Anna Owczarzak

Malgorzata Skuza

Lidia Wolska

Teresa Stachowicz-Stencel

机构：

[1] Medical University of Gdansk,Department of Pediatrics, Hematology and Oncology

[2] Gdansk University of Technology,Department of Molecular Biotechnology and Microbiology

[3] Medical University of Bialystok,Department of Pediatric Oncology and Hematology

[4] Medical University of Gdansk,Department of Environmental Toxicology

[5] Medical University of Gdansk,Department of Clinical Nutrition

[6] The Polish Red Cross Maritime Hospital,Diagnostic Imaging Department

来源：

Amino Acids | 2021年 / 53卷

关键词：

Amino acid profile; Metabolomics; Cancer; Tumor biomarkers;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Amino acids (AAs) play a crucial role in cancer cell metabolism. Levels of 22 plasma AAs at the time of diagnosis and after treatment were established among 39 pediatric cancer patients and 33 healthy children. Glutamic acid levels decreased and tryptophan levels increased during treatment. Cancer patients presented significantly lower levels of glutamine and leucine post-treatment while levels of 12 other AAs were higher comparing to controls. Results suggest that plasma free AA profile may serve as a prognostic biomarker.

引用

页码：133 / 138

页数：5

共 50 条

[31] Diagnostic value of abdominal follow-up sonography in polytrauma patients A retrospective study
Lichtenstein, Thorsten
Chang, De-Hua
Sokolowski, M.
Hokamp, N. Grosse
Berninger, M. T.
Simons, R. M.
Hellmich, M.
Maintz, D.
Henning, T. D.
MEDICINE, 2020, 99 (42)
[32] PLASMA PROLACTIN IN PATIENTS WITH COLORECTAL-CANCER - VALUE IN FOLLOW-UP AND AS A PROGNOSTICATOR
PATEL, DD
BHATAVDEKAR, JM
GHOSH, N
VORA, HH
KARELIA, NH
SHAH, NG
SUTHAR, TP
BALAR, DB
TRIVEDI, CR
CANCER, 1994, 73 (03) : 570 - 574
[33] Prognostic role of undetectable ablation thyroglobulin and follow-up thyroglobulin in patients with thyroid cancer
Sophie Leboulleux
Nature Clinical Practice Endocrinology & Metabolism, 2008, 4 : 436 - 437
[34] Prognostic role of undetectable ablation thyroglobulin and follow-up thyroglobulin in patients with thyroid cancer
Leboulleux, Sophie
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (08): : 436 - 437
[35] PROGNOSTIC SIGNIFICANCE OF CIRCULATING TUMOUR CELLS - A 5-YEAR FOLLOW-UP STUDY OF PATIENTS WITH CANCER OF BREAST
WEBSTER, DR
SABBADIN.E
CANADIAN MEDICAL ASSOCIATION JOURNAL, 1967, 96 (03) : 129 - &
[36] An overview of ocogenetic diagnostic and patients follow-up in Romanian hereditary cancer predisposition families
Negura, Lucian
Chicos, Andrei
Negura, Anca
ANNALS OF ONCOLOGY, 2017, 28 : 109 - 109
[37] Risk factors for lack of adherence with diagnostic follow-up care in breast cancer patients
Labilloy, Guillaume
Celso, Brian
Jasra, Bharti
Neumayer, Leigh
Mobley, Erin
Smotherman, Carmen
Brailsford, Jennifer
CANCER RESEARCH, 2022, 82 (04)
[38] DIAGNOSTIC PERFORMANCE OF PAPSMEAR AND HPV-TESTING IN THE FOLLOW-UP OF PATIENTS WITH CERVICAL CANCER
Rave Ramirez, Andres
Arencibia Sanchez, Octavio
Molero Sala, Laura
Gonzalez Garcia-Cano, Daniel
Martin Martinez, Alicia
Navarro, Beatriz
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A67 - A67
[39] EVALUATION OF ROUTINE DIAGNOSTIC-TESTS FOR FOLLOW-UP OF PATIENTS WITH COLORECTAL-CANCER
BERARDI, RS
MARIS, C
MADRID, A
BECKNELL, WE
DEWALL, BT
AMERICAN JOURNAL OF PROCTOLOGY GASTROENTEROLOGY & COLON & RECTAL SURGERY, 1980, 31 (03) : 23 - 27
[40] Phospholipase A2 expression in prostate cancer as a biomarker of good prognosis: A comprehensive study in patients with long follow-up
Recuero, Saulo da Cunha
Viana, Nayara, I
Reis, Sabrina T.
Mendes, Keith T.
Talib, Leda L.
Gattaz, Wagner F.
Guimaraes, Vanessa R.
Silva, Iran A.
Pimenta, Ruan C. P.
Camargo, Juliana A.
Nahas, Willian C.
Srougi, Miguel
Leite, Katia R. M.
UROLOGIA JOURNAL, 2024, 91 (04) : 720 - 726

← 1 2 3 4 5 →